Biossil

Biossil operates as an artificial intelligence native biopharma organization that applies advanced computational models to drug discovery and repositioning. This innovative approach allows the team to rapidly identify new therapeutic uses for existing compounds to treat life-threatening conditions.

NewsHeat chart

  • Week
  • Month
  • Year
  • Media news
  • Corp news
Click to unlock the chart

The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice

Company Valuation

  • Valuation
  • Share Price
  • Cumulative Funding

The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.

Funding Round
Funding Amount
Post-Money Valuation
Share Price
Venture28 Sep, 2026
***
***
***
Venture20 Apr, 2026
***
***
***
Venture1 Jan, 2024
***
***
***
Seed1 Jan, 2023
***
***
***

*** - To view the data, please log into your account or create a new one.

Company valuation calculator

To calculate, specify one of the parameters

News related to Biossil1

Filter by
Sort by
Biossil
Sep 29, 2026 •Show on chart

OpenAI Leads $153 Million Round for Biossil at $1 Billion Valuation

The all-equity deal values Biossil at US$1 billion and includes a small portion paid to early employees. ...

https://www.startupresearcher.com/news/openai-leads-usd153-million-round-for-biossil-at-usd1-billion-valuation

Investors3

OpenAIOpenAI
Founders FundFounders Fund
137 Ventures137 Ventures